Quantum Genesis AI Announces Removal of OTC Markets Caveat Emptor Designation

Quantum Genesis AI Corp. (OTC: QGAI) announced today that the Caveat Emptor designation previously applied to the Company's securities by OTC Markets Group has been removed. The designation, which warns investors of potential risks, was lifted after the company engaged with OTC Markets throughout the review process and provided necessary information.

The removal of the Caveat Emptor label is a significant milestone for Quantum Genesis AI, as it indicates the company has addressed the concerns that led to the designation. The company acknowledged the professionalism and assistance provided by OTC Markets during the review. "We appreciate the time and attention that OTC Markets dedicated to this matter and are pleased that the review process has concluded with the removal of the Caveat Emptor designation," said Naveen Kulkarni, Chief Executive Officer of Quantum Genesis AI Corp. "Throughout this process, our focus remained on transparency, responsiveness, and constructive engagement. We thank OTC Markets for their professionalism and assistance, and we remain committed to maintaining open communication with our shareholders and the marketplace."

The Caveat Emptor designation is typically applied to companies that have experienced significant public interest, promotional activity, or other factors that may affect the accuracy of information available to investors. Its removal suggests that OTC Markets has reviewed the company's disclosures and found them to be in order. For investors, this development reduces a layer of risk associated with the stock and may improve the company's standing in the market.

Quantum Genesis AI continues to advance its strategic initiatives in artificial intelligence, computational modeling, and scientific innovation. The company remains committed to responsible corporate governance and public company compliance. According to the press release, the company intends to provide timely updates regarding its business activities and corporate developments through its public disclosures and shareholder communications.

Investors can find more information on the company's website at www.qgaicorp.com and its profile on OTC Markets at www.otcmarkets.com/stock/QGAI.

The removal of the Caveat Emptor designation is a positive step for Quantum Genesis AI, potentially opening the door for increased investor confidence and liquidity. It underscores the company's dedication to transparency and regulatory compliance, which are crucial for its long-term growth in the competitive AI sector.